UroCareLive

CME Speakers

 

  • Daniel J. George, MD

    Daniel J. George, MD

    Daniel J. George, MD

    Professor of Medicine and Surgery, Divisions of Medical Oncology and Urology

    Daniel J. George, MD, is a professor of medicine and surgery in the Divisions of Medical Oncology and Urology at Duke University School of Medicine in Durham, North Carolina. He also has appointments in the Duke Clinical Research Institute and the Duke Cancer Institute, where he is the director of genitourinary (GU) oncology. Dr George’s areas of research include new drug development and biomarkers of GU cancers with an emphasis on signal transduction pathways and angiogenesis. He leads the Duke site for the Department of Defense Prostate Cancer Clinical Trials Consortium, specializing in Phase I and II studies in prostate cancer. Dr George is an internationally recognized clinical researcher and thought leader in GU malignancies, with over 150 peer-reviewed publications.
  • Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    Neal D. Shore, MD, FACS

    President

    Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 250 clinical trials that focus mainly on GU oncology, serves on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 125 peer-reviewed publications, several book chapters, and is a peer reviewer for Lancet Oncology, Urology, and numerous other journals. He earned his MD from Duke University Medical School.